Literature DB >> 2882540

Yawning is elicited by D2 dopamine agonists but is blocked by the D1 antagonist, SCH 23390.

G Serra, M Collu, G L Gessa.   

Abstract

The subtype of dopamine (DA) receptors mediating the yawning response to DA agonists was determined in rats. Yawning was elicited both by the mixed D1-D2 agonist apomorphine and by the specific D2 agonist LY 171555, but not by the selective D1 agonist SKF 38393. Both apomorphine- and LY 171555-induced yawning were antagonized not only by the selective D2 antagonist sulpiride but, unexpectedly, also by the selective D1 antagonist SCH 23390. The results suggest that DA receptors mediating the yawning response are of the D2 type, and that these receptors are connected with D1 receptors in such a way that the blockade of the latter results in the functional inactivation of the former.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2882540     DOI: 10.1007/bf00518186

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  31 in total

Review 1.  Multiple receptors for dopamine.

Authors:  J W Kebabian; D B Calne
Journal:  Nature       Date:  1979-01-11       Impact factor: 49.962

2.  Drugs affecting dopamine neurons and yawning behavior.

Authors:  E Mogilnicka; V Klimek
Journal:  Pharmacol Biochem Behav       Date:  1977-10       Impact factor: 3.533

3.  Evidence for dopamine receptors in the human brain mediating sedation and sleep.

Authors:  G U Corsini; M Del Zompo; S Manconi; M P Piccardi; P L Onali; A Mangoni
Journal:  Life Sci       Date:  1977-05-01       Impact factor: 5.037

4.  [3H]SCH 23390 binding sites increase after chronic blockade of D-1 dopamine receptors.

Authors:  M L Porceddu; E Ongini; G Biggio
Journal:  Eur J Pharmacol       Date:  1985-12-03       Impact factor: 4.432

5.  Antagonism of the apomorphine-induced yawning by "atypical" neuroleptics.

Authors:  I Dubuc; P Protais; O Colboc; J Costentin
Journal:  Neuropharmacology       Date:  1982-11       Impact factor: 5.250

6.  Effects of the potential neuroleptic peptide des-tyrosine-gamma-endorphin and haloperidol on apomorphine-induced behavioural syndromes in rats and mice.

Authors:  V J Nickolson; H H Berendsen
Journal:  Life Sci       Date:  1980-10-13       Impact factor: 5.037

Review 7.  Two dopamine receptors: biochemistry, physiology and pharmacology.

Authors:  J C Stoof; J W Kebabian
Journal:  Life Sci       Date:  1984-12-03       Impact factor: 5.037

8.  Dopaminergic behaviour stereospecific promoted by the D1 agonist R-SK & F 38393 and selectively blocked by the D1 antagonist SCH 23390.

Authors:  A G Molloy; J L Waddington
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

9.  Effects of the putative D-1 antagonist SCH 23390 on stereotyped behaviour induced by the D-2 agonist RU24213.

Authors:  M T Pugh; K M O'Boyle; A G Molloy; J L Waddington
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

10.  Cycloheximide prevents apomorphine-induced yawning, penile erection and genital grooming in rats.

Authors:  G Serra; W Fratta; M Collu; L Napoli-Farris; G L Gessa
Journal:  Eur J Pharmacol       Date:  1982-12-24       Impact factor: 4.432

View more
  11 in total

1.  Occurrence of yawning and decrease of prolactin levels via stimulation of dopamine D2-receptors after administration of SND 919 in rats.

Authors:  S Matsumoto; K Yamada; M Nagashima; M Domae; K Shirakawa; T Furukawa
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-07       Impact factor: 3.000

2.  Involvement of central beta-adrenoceptors in the regulation of yawning responses.

Authors:  K Yamada; S Matsumoto; M Nagashima; M Kumagai; H Kimura; T Furukawa
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-07       Impact factor: 3.000

3.  The NK-3 tachykinin agonist senktide elicits yawning and chewing mouth movements following subcutaneous administration in the rat. Evidence for cholinergic mediation.

Authors:  A J Stoessl; C T Dourish; S D Iversen
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

Review 4.  Pathophysiology of Migraine: A Disorder of Sensory Processing.

Authors:  Peter J Goadsby; Philip R Holland; Margarida Martins-Oliveira; Jan Hoffmann; Christoph Schankin; Simon Akerman
Journal:  Physiol Rev       Date:  2017-04       Impact factor: 37.312

5.  Behavioral effects of selective and nonselective dopamine agonists on young rats after irreversible antagonism of D1 and/or D2 receptors.

Authors:  S A McDougall; C A Crawford; A J Nonneman
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

6.  Induction of tolerance of dopaminergic responses in man.

Authors:  S Lal; J X Thavundayil; N M K Ng Ying Kin; X Dai; G Schwartz; A Montoya
Journal:  J Neural Transm (Vienna)       Date:  2008-05-28       Impact factor: 3.575

7.  Perinatal Treatments with the Dopamine D₂-Receptor Agonist Quinpirole Produces Permanent D₂-Receptor Supersensitization: a Model of Schizophrenia.

Authors:  Richard M Kostrzewa; Przemysław Nowak; Ryszard Brus; Russell W Brown
Journal:  Neurochem Res       Date:  2015-11-07       Impact factor: 3.996

8.  Apomorphine-induced yawning in rats is abolished by bilateral 6-hydroxydopamine lesions of the substantia nigra.

Authors:  A J Stoessl; C T Dourish; S D Iversen
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

9.  Role of dopamine receptors in the dual effect of naloxone on quinpirole-induced yawning in morphine pretreated rats.

Authors:  A Zharkovsky; J Moisio; T Kivastik; L Ahtee
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-05       Impact factor: 3.000

10.  Possible involvement of differing classes of dopamine D-2 receptors in yawning and stereotypy in rats.

Authors:  K Yamada; M Nagashima; H Kimura; S Matsumoto; T Furukawa
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.